These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 20851938)

  • 1. Microbubble-enhanced US in body imaging: what role?
    Wilson SR; Burns PN
    Radiology; 2010 Oct; 257(1):24-39. PubMed ID: 20851938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Voiding urosonography: an additional important indication for use of US contrast agents.
    Darge K
    Radiology; 2011 May; 259(2):614-5; author reply 615. PubMed ID: 21502399
    [No Abstract]   [Full Text] [Related]  

  • 3. Contrast-enhanced ultrasound in the detection and characterization of liver tumors.
    Jang HJ; Yu H; Kim TK
    Cancer Imaging; 2009 Nov; 9(1):96-103. PubMed ID: 19933022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood flow patterns in focal liver lesions at microbubble-enhanced US.
    Brannigan M; Burns PN; Wilson SR
    Radiographics; 2004; 24(4):921-35. PubMed ID: 15256618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-Enhanced Ultrasound of Focal Liver Masses: A Success Story.
    Wilson SR; Burns PN; Kono Y
    Ultrasound Med Biol; 2020 May; 46(5):1059-1070. PubMed ID: 32059917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of malignant liver masses: characterization and detection.
    Jang HJ; Kim TK; Wilson SR
    Ultrasound Q; 2006 Mar; 22(1):19-29. PubMed ID: 16641790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
    Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
    J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harmonic hepatic US with microbubble contrast agent: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.
    Wilson SR; Burns PN; Muradali D; Wilson JA; Lai X
    Radiology; 2000 Apr; 215(1):153-61. PubMed ID: 10751481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
    Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
    Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced ultrasound with perflubutane microbubble agent: evaluation of differentiation of hepatocellular carcinoma.
    Takahashi M; Maruyama H; Ishibashi H; Yoshikawa M; Yokosuka O
    AJR Am J Roentgenol; 2011 Feb; 196(2):W123-31. PubMed ID: 21257852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging of focal liver lesions.
    Jang HJ; Yu H; Kim TK
    Semin Roentgenol; 2009 Oct; 44(4):266-82. PubMed ID: 19715792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced ultrasound in the diagnosis of nodules in liver cirrhosis.
    Kim TK; Jang HJ
    World J Gastroenterol; 2014 Apr; 20(13):3590-6. PubMed ID: 24707142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
    Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of liver lesions by real-time contrast-enhanced ultrasonography.
    Celli N; Gaiani S; Piscaglia F; Zironi G; Camaggi V; Leoni S; Righini R; Bolondi L
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):3-14. PubMed ID: 17206071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterizing malignant liver lesions with contrast-enhanced ultrasound.
    Wills M; Harvey CJ; Kuzmich S; Afaq A; Lim A; Cosgrove D
    Br J Hosp Med (Lond); 2014 Mar; 75(3):151-4. PubMed ID: 24621631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign liver masses: imaging with microbubble contrast agents.
    Kim TK; Jang HJ; Wilson SR
    Ultrasound Q; 2006 Mar; 22(1):31-9. PubMed ID: 16641791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging.
    Wilson SR; Burns PN
    Semin Liver Dis; 2001 May; 21(2):147-59. PubMed ID: 11436569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbubble-enhanced ultrasound for the antivascular treatment and monitoring of hepatocellular carcinoma.
    D'Souza JC; Sultan LR; Hunt SJ; Gade TP; Karmacharya MB; Schultz SM; Brice AK; Wood AKW; Sehgal CM
    Nanotheranostics; 2019; 3(4):331-341. PubMed ID: 31687321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.